Manuel Nicolás
Hernández Guerra de Aguilar
Profesor Titular Universidad
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (8)
2023
-
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology, Vol. 77, Núm. 4, pp. 1095-1105
-
Hematological Composite Scores in Patients with Inflammatory Bowel Disease
Journal of Clinical Medicine, Vol. 12, Núm. 23
2021
-
Carotid plaque assessment reclassifies patients with inflammatory bowel disease into very-high cardiovascular risk
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Insulin resistance is not increased in inflammatory bowel disease patients but is related to non-alcoholic fatty liver disease
Journal of Clinical Medicine, Vol. 10, Núm. 14
-
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257
-
Qrisk3 performance in the assessment of cardiovascular risk in patients with inflammatory bowel disease
Journal of Clinical Medicine, Vol. 10, Núm. 18
2019
-
Chronic kidney disease staging with cystatin C or creatinine-based formulas: Flipping the coin
Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 287-294
-
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
Journal of Hepatology, Vol. 71, Núm. 4, pp. 666-672